China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.95 Billion CNY | -1.34% |
| 2022 | 6.03 Billion CNY | 19.77% |
| 2021 | 5.04 Billion CNY | 2.74% |
| 2020 | 4.9 Billion CNY | 4.62% |
| 2019 | 4.69 Billion CNY | 4.66% |
| 2018 | 4.48 Billion CNY | 26.21% |
| 2017 | 3.55 Billion CNY | 87.51% |
| 2016 | 1.89 Billion CNY | 53.27% |
| 2015 | 1.23 Billion CNY | 195.88% |
| 2014 | 417.69 Million CNY | 3.01% |
| 2013 | 405.5 Million CNY | 153.56% |
| 2012 | 159.92 Million CNY | -15.53% |
| 2011 | 189.33 Million CNY | 31.48% |
| 2010 | 144 Million CNY | 42.17% |
| 2009 | 101.28 Million CNY | 39.51% |
| 2008 | 72.6 Million CNY | 6.32% |
| 2007 | 68.28 Million CNY | 17.44% |
| 2006 | 58.14 Million CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| 2004 | - CNY | 0.0% |
| 2003 | - CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | 0.0% |
| 2000 | - CNY | 0.0% |
| 1999 | - CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 5.58 Billion CNY | -6.27% |
| 2024 Q2 | 5.58 Billion CNY | 0.0% |
| 2023 Q3 | 5.95 Billion CNY | 5.93% |
| 2023 Q4 | 5.95 Billion CNY | 0.0% |
| 2023 FY | 5.95 Billion CNY | -1.34% |
| 2023 Q2 | 5.62 Billion CNY | 0.0% |
| 2023 Q1 | 5.62 Billion CNY | -6.86% |
| 2022 Q1 | 6.01 Billion CNY | 19.26% |
| 2022 Q3 | 6.03 Billion CNY | 0.43% |
| 2022 Q4 | 6.03 Billion CNY | 0.0% |
| 2022 FY | 6.03 Billion CNY | 19.77% |
| 2022 Q2 | 6.01 Billion CNY | 0.0% |
| 2021 Q4 | 5.04 Billion CNY | -2.15% |
| 2021 Q1 | 5.32 Billion CNY | 8.54% |
| 2021 Q3 | 5.15 Billion CNY | -3.26% |
| 2021 Q2 | 5.32 Billion CNY | 0.0% |
| 2021 FY | 5.04 Billion CNY | 2.74% |
| 2020 Q2 | 4.8 Billion CNY | 0.0% |
| 2020 Q4 | 4.9 Billion CNY | -2.05% |
| 2020 FY | 4.9 Billion CNY | 4.62% |
| 2020 Q1 | 4.8 Billion CNY | 2.38% |
| 2020 Q3 | 5.01 Billion CNY | 4.32% |
| 2019 Q2 | 4.24 Billion CNY | 0.0% |
| 2019 Q4 | 4.69 Billion CNY | -3.21% |
| 2019 Q3 | 4.84 Billion CNY | 14.11% |
| 2019 Q1 | 4.24 Billion CNY | -5.24% |
| 2019 FY | 4.69 Billion CNY | 4.66% |
| 2018 Q4 | 4.48 Billion CNY | 0.0% |
| 2018 Q1 | 4.1 Billion CNY | 15.54% |
| 2018 FY | 4.48 Billion CNY | 26.21% |
| 2018 Q2 | 4.1 Billion CNY | 0.0% |
| 2018 Q3 | 4.48 Billion CNY | 9.24% |
| 2017 Q4 | 3.55 Billion CNY | 0.0% |
| 2017 Q1 | 2.57 Billion CNY | 35.94% |
| 2017 Q3 | 3.55 Billion CNY | 37.94% |
| 2017 FY | 3.55 Billion CNY | 87.51% |
| 2017 Q2 | 2.57 Billion CNY | 0.0% |
| 2016 Q3 | 1.89 Billion CNY | 40.01% |
| 2016 Q2 | 1.35 Billion CNY | 0.0% |
| 2016 Q1 | 1.35 Billion CNY | 9.47% |
| 2016 Q4 | 1.89 Billion CNY | 0.0% |
| 2016 FY | 1.89 Billion CNY | 53.27% |
| 2015 Q2 | 360.85 Million CNY | 0.0% |
| 2015 Q4 | 1.23 Billion CNY | 0.0% |
| 2015 FY | 1.23 Billion CNY | 195.88% |
| 2015 Q3 | 1.23 Billion CNY | 242.48% |
| 2015 Q1 | 360.85 Million CNY | -13.61% |
| 2014 Q2 | 386.12 Million CNY | 0.0% |
| 2014 FY | 417.69 Million CNY | 3.01% |
| 2014 Q4 | 417.69 Million CNY | 0.0% |
| 2014 Q1 | 386.12 Million CNY | -4.78% |
| 2014 Q3 | 417.69 Million CNY | 8.18% |
| 2013 Q3 | 405.5 Million CNY | 99.13% |
| 2013 FY | 405.5 Million CNY | 153.56% |
| 2013 Q4 | 405.5 Million CNY | 0.0% |
| 2013 Q2 | 203.63 Million CNY | -0.75% |
| 2013 Q1 | 205.16 Million CNY | 28.29% |
| 2012 Q3 | 161.04 Million CNY | -11.17% |
| 2012 FY | 159.92 Million CNY | -15.53% |
| 2012 Q2 | 181.29 Million CNY | 0.0% |
| 2012 Q4 | 159.92 Million CNY | -0.7% |
| 2011 Q4 | 189.33 Million CNY | 0.0% |
| 2011 Q2 | 190.56 Million CNY | 0.0% |
| 2011 FY | 189.33 Million CNY | 31.48% |
| 2010 Q4 | 144 Million CNY | 0.0% |
| 2010 FY | 144 Million CNY | 42.17% |
| 2010 Q2 | 139.91 Million CNY | 0.0% |
| 2009 Q4 | 101.28 Million CNY | 0.0% |
| 2009 FY | 101.28 Million CNY | 39.51% |
| 2009 Q2 | 98.26 Million CNY | 0.0% |
| 2008 FY | 72.6 Million CNY | 6.32% |
| 2008 Q4 | 72.6 Million CNY | 0.0% |
| 2007 FY | 68.28 Million CNY | 17.44% |
| 2006 FY | 58.14 Million CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |
| 2004 FY | - CNY | 0.0% |
| 2003 FY | - CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2001 FY | - CNY | 0.0% |
| 2000 FY | - CNY | 0.0% |
| 1999 FY | - CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -48757.502% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | -329.133% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -81925.451% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -1834.173% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -1280.116% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -1899.003% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -9385.78% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -5964.304% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -3293.651% |
| SSY Group Limited | 1.08 Billion HKD | -448.582% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -6406.687% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -1774.789% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 83.02% |